Related Experiment Video
Updated: May 7, 2026
10:19
Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Published on: August 22, 2014
Toward priorities for aging research.
1Leading Technology Group Pty Ltd. , Australia .
Rejuvenation Research
|October 8, 2013
Summary
Aging populations need research priorities. Vascular aging, including heart disease and stroke, is the top priority for aging research, yet funding is misaligned with these health needs.
Area of Science:
- Gerontology
- Public Health
- Mortality Modeling
Background:
- Global populations are aging, with age as a primary mortality risk factor.
- Current aging research lacks defined priorities despite significant impact on global health.
- Distinct chronic processes influence mortality before and after reproductive age.
Purpose of the Study:
- To propose a ranking method for identifying aging research priorities.
- To align research funding with critical health needs in aging populations.
Main Methods:
- Literature review of mortality modeling.
- Development of a ranking system based on disease-specific death percentages in the over-60 population.
- Analysis of senescent processes as underlying causes of age-related mortality.
Main Results:
- Vascular aging, specifically ischemic heart disease and stroke, identified as the most critical area for aging research.
- A significant disconnect exists between current health funding and established aging research priorities.
- Senescent processes are identified as the primary drivers of mortality in older adults.
Conclusions:
- Prioritizing research on vascular aging is crucial for improving health outcomes in aging populations.
- Realigning funding with research priorities is essential for societal health.
- Addressing senescent processes offers a pathway to mitigate age-related mortality.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...